Profile

Stephen B. Tatter, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

219 Ratings
27 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor,


Clinical Interests

Brain Tumors, Gamma Knife, Neurosurgery, Parkinson's Disease, Pituitary Tumors, Tremor

Contact Information

Department: 336-716-4081

Insurance Accepted »

Media Medical Expert »

Related Links

Education & Training

  • B.S., University of Michigan/Ann Arbor, 1982
  • M.D., Cornell University Medical College, 1990
  • Ph.D., Rockefeller University, 1990
  • Residency, Surgery, Massachusetts Gen Hosp, 1996
  • Fellowship, Harvard Medical School, 1997

NPI Number

  • 1831178151
Stephen B. Tatter, M.D., Ph.D.

Doctor Rating

4.8 out of 5

219 Ratings
27 Comments
 

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery
Brain Tumor Center of Excellence
Comprehensive Cancer Center

Research Interests

cancer/oncogenesis, cognition/learning, health services, research/outc, neurosciences/behavior, physical/muscular function

Contact Information

Academic: 336-716-4047 | Department: 336-716-4081

Media Medical Expert »

Related Links

Recent Publications

Swan BD, Brocker DT, Hilliard JD, Tatter SB, Gross RE, Turner DA, Grill WM. Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting. Clin Neurophysiol. 2016;127(2):1551-1559.

Kishida KT, Saez I, Lohrenz T, Witcher MR, Laxton AW, Tatter SB, White JP, Ellis TL, Phillips PE, Montague PR.. Subsecond dopamine fluctuations in human striatum encode superposed error signals about actual and counterfactual reward. Proc Natl Acad Sci U S A. 2016;113(1):200-205.

Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS. Association between subthalamic nucleus deep brain stimulation and weight gain: results of a case-control study. Clin Neurol Neurosurg. 2016;140():38-42.

McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD. Emerging indications for fractionated gamma knife radiosurgery. Neurosurgery. 2016;():.

Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015;22(3):561-565.

Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536-542.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol. 2015;123(1):171-177.

Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Rodriguez A, Tatter SB. Neurosurgical management of brain metastases. Curr Probl Cancer. 2015;39(2):89-98.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015;6(22):18945-55.

Rodriguez A, Tatter SB, Debinski W. Neurosurgical techniques for disruption of the blood-brain barrier for glioblastoma treatment. Pharmaceutics. 2015;7(3):175-187.

Helis CA, Lucas JT Jr, Bourland JD, Chan MD, Tatter SB, Laxton AW. Repeat radiosurgery for trigeminal neuralgia. Neurosurgery. 2015;77(5):755-761.

Strowd RE, Russell G, Harmon M, Carter AF, Chan MD, Tatter SB, Laxton AW, High K, Lesser G. Immunologic response to high-dose influenza vaccination in patients with primary central nervous system malignancy (PCNSM) [abstract]. J Clin Oncol. 2015;33(15 Suppl):e20669.

Black PJ, Page BR, Lucas JT Jr, Hughes RT, Laxton AW, Tatter SB, Munley MT, Chan MD. Factors that determine local control with gamma knife radiosurgery: the role of primary histology. J Radiosurg SBRT. 2015;3(4):281-286.

Zheng ZL, Morykwas MJ, Tatter S, Gordon S, McGee M, Green H, Argenta LC. Ameliorating spinal cord injury in an animal model with mechanical tissue resuscitation. Neurosurgery. 2015;():.

Holmes JA, Paulsson AK, Page BR, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Genomic predictors of patterns of progression in glioblastoma and possible influences on radiation field design. J Neurooncol. 2015;124(3):447-453.

Triffo WJ, Bourland JD, Couture DE, McMullen KP, Tatter SB, Morris PP. Definitive treatment of vein of Galen aneurysmal malformation with stereotactic radiosurgery. J Neurosurg. 2014;120(1):120-125.

Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014;120(3):433-441.

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014;37(2):177-181.

Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T [deceased], Blevins M, High K, Lesser GJ. Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol. 2014;16(12):1639-1644.

Zheng ZL, Morykwas M, Campbell D, McGee M, Hollingsworth C, Adams F, Mays J, Tatter S, Argenta L. Mechanical tissue resuscitation at the site of traumatic brain injuries reduces the volume of injury and hemorrhage in a swine model. Neurosurgery. 2014;75(2):152-162.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014;16(9):1283-1288.

Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg. 2014;82(6):1250-1255.

Witcher M, Moran R, Tatter SB, Laxton AW. Neuronal oscillations in Parkinson's disease. Front Biosci (Landmark Ed). 2014;19():1291-1299.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.

Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol. 2014;120(1):163-169.

Kuhn EN, Taksler GB, Dayton O, Loganathan A, Bourland D, Tatter SB, Laxton AW, Chan MD. Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis. Neurosurgery. 2014;75(5):536-545.

Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD. Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S245.

Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD. Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD. Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

Lucas JT, Ayala-Peacock DN, Piazza M, Kuremsky JG, Page BR, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD. A propensity score adjusted analysis of patients receiving up-front SRS versus WBRT: does the use of upfront WBRT really affect neurologic death? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S315-S316.

Debinski W, Rodriguez A, Gibo D, Tatter SB, Mott R, Lively M, Miller L, Seals DF. Functional presence of M2 macrophage markers in GBM tumor cells [abstract]. Neuro Oncol. 2014;16(Suppl 3):.

Liu Y, Konrad PE, Neimat JS, Tatter SB, Yu H, Datteri RD, Landman BA, Noble JH, Pallavaram S, Dawant BM, D'Haese PF. Multisurgeon, multisite validation of a trajectory planning algorithm for deep brain stimulation procedures. IEEE Trans Biomed Eng. 2014;61(9):2479-2487.

Mohammadi AM, Hawasli AH, Rodriguez A, Schroeder JL, Laxton AW, Elson P, Tatter SB, Barnett GH, Leuthardt EC. The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med. 2014;3(4):971-979.

Strowd R, Russell G, Harmon M, Carter A, Chan M, Tatter S, Laxton A, High K, Lesser G. A pilot study of high-dose influenza vaccine immunogenicity in patients with primary central nervous system malignancy [abstract]. Neuro Oncol. 2014;16(Suppl 5):v207.

Kuremsky JG, Lester SC, Lucas JT, Randolph DM, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on whether metastases are symptomatic or not: an argument for routine brain screening [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S178-S179.

Lucas JT, Colmer HG, White GL, Isom SP, Ellis TL [deceased], Urbanic JJ, Tatter SB, Chan MD. A competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage following whole brain radiation therapy failure (WBRT): who actually dies of their brain metastases? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S52.

Randolph D, Peiffer AM, Klepin H, Ayala-Peacock DN, Lester SC, Laxton AW, Tatter SB, Shaw EG, Chan MD. Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S609.

Kuhn EN, Taksler GB, Dayton O, Loganathan AG, Vern-Gross TZ, Bourland JD, Laxton AW, Chan MD, Tatter SB. Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas. Neurosurg Focus. 2013;35(6):E14.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL [deceased], McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013;73(4):641-647.

Mohammadi A, Hawasli A, Rodriguez A, Schroeder J, Laxton A, Elson P, Tatter S, Barnett G, Leuthardt E. Laser Interstitial Thermal Therapy (LITT) as a treatment modality for difficult-to-access high grade gliomas: a multi-center study [abstract]. Neuro Oncol. 2013;15(Suppl 3):221.

Bergene J, Walker J, Tatter S, Sarwal A. Cerebral vasospasm post craniopharyngioma surgery with diabetes insipidus: challenges of management [abstract]. Crit Care Med. 2013;41(12 Suppl 1):A330.

Brocker DT, Swan BD, Turner DA, Gross RE, Tatter SB, Koop MM, Bronte-Stewart H, Grill WM. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol. 2013;239():60-67.

Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747-753.

Powers AK, Neal MT, Argenta LC, Wilson JA, DeFranzo AJ, Tatter SB. Vacuum-assisted closure for complex cranial wounds involving the loss of dura mater. J Neurosurg. 2013;118(2):302-308.

Chan MD, Shaw EG, Tatter SB. Radiosurgical management of trigeminal neuralgia. Neurosurg Clin N Am. 2013;24(4):613-621.

Kuhn E, Taksler GB, Dayton O, Loganathan A, Bourland J, Ellis TL [deceased], Laxton AW, Shaw EG, Chan MD, Tatter SB. Adverse toxicity after stereotactic radiosurgery for treatment of meningiomas [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S259.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurosurgery

Clinical Interests

Brain Tumors, Gamma Knife, Neurosurgery, Parkinson's Disease, Pituitary Tumors, Tremor
Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery
Brain Tumor Center of Excellence
Comprehensive Cancer Center

Doctor Rating

4.8 out of 5

Stephen B. Tatter, M.D., Ph.D.219 Ratings
27 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/2/2016

*Tatter was very personable.

2/27/2016

Excellent care throughout the surgical process.

2/17/2016

good

2/15/2016

I really feel Dr. Tatter saved my life by keeping me out of surgery. I wish I been referred to him when I was first diagnosed with chiari malformation and probably would have been able to avoid my first brain surgery. My life would be so different right now. The professionalism of Wake Forest is amazing as so is Dr. Tatter. I chose both over Duke Hospital and Dr. Alan Friedman, and I am so thankful I did everyday.

2/5/2016

Good.

2/5/2016

Could not ask for better care from doctor and his physician ass't.!

1/27/2016

Excellent surgeon.

1/19/2016

Was my first time seeing Dr. Tatter and his staff. I am a former patient for Dr. Thomas Ellis and this was a routine check up. I have nothing but wonderful things to say Dr. Tatter and his staff.

1/12/2016

Good.

12/28/2015

Dr Tatter is top notch!! I am retired US Army and if it were up to me he would be a General in his field! I cannot say enough good about him!

12/21/2015

*Dr. Tatter is ABSOLUTELY SUPERB - knowledgeable, friendly, professional, caring a blessing to his pts. *DR. TATTER

12/16/2015

Dr. Tatter is very thorough and has a wonderful bedside manner. He takes time to fully discuss my prognosis and next steps. He very thoughtfully considers the best strategy for my care and discusses those options with me. I have no hesitation in recommending him to family and friends and often do.

12/15/2015

Would highly recommend him.

10/31/2015

Dr. Tatter's office and Dr. Tatter were very gracious with our being delayed by MRI

8/31/2015

Everything but the wait was excellent. Dr. Tatter/ Rich are awesome but always behind. I have been first appointmenet and waited 30 mins

8/25/2015

Very pleased.

8/24/2015

Very personable $ informative.

8/24/2015

I had not seen the doctor in 5 years and he seemed to remember me or at least my case.

8/21/2015

*Dr. Tatter was super nice & professional.

7/29/2015

Good.

7/6/2015

I had an outstanding experience with Dr. Stephen Tatter. He explained my situation very well and in a way that I could easily understand my situation. He also reiterated all of my options and explained why the option chosen was the best for me.

6/16/2015

This was my first visit with Dr. Tatter. He and all of his staff made me feel welcome, valued, heard, and understood.

6/12/2015

I am cancer free so to me *Dr. Tatter is the best.

6/8/2015

Confident, professional, and put us at ease.

5/19/2015

Dr Tatter and his staff are truly exceptional

5/15/2015

Dr Tatter and PA Lowder both are encouraging and forthcoming about my condition. They are quick to respond to My Wake Health questions. I am very confident that I am in good hands.

5/8/2015

*Dr. Tatter is one of the finest doctors I have every had.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.